| Joan M Lebel, MD | |
|
230 Worcester St, Wellesley, MA 02481-5420 | |
| (781) 431-5200 | |
| (781) 431-5298 |
| Full Name | Joan M Lebel |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 230 Worcester St, Wellesley, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114906740 | NPI | - | NPPES |
| E05142 | Other | MA | BLUE CROSS |
| 0015116 | Other | MA | NEIGHBORHOOD HEALTH |
| 039886 | Other | MA | TUFTS |
| PP120 | Other | MA | HARVARD PILGRIM |
| 2067153 | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 39886 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Joan M Lebel, MD 147 Milk St, Provider Enrollment - 9th Floor, Boston, MA 02109-4806 Ph: (617) 559-8053 | Joan M Lebel, MD 230 Worcester St, Wellesley, MA 02481-5420 Ph: (781) 431-5200 |
News Archive
A lack of leadership, donor disagreements and overarching disorganization has led Haiti to make little progress in its rebuilding effort since the January 12 earthquake, according to a U.S. Senate report expected to be released on Tuesday, the Associated Press reports.
Mammograms have helped to lower death rates from breast cancer, but a new report by the Institute of Medicine suggest a lot more needs to be done to improve breast cancer screening and save even more lives.
New research has highlighted the potential gender gap in stress, with women reporting higher stress from life events such as death of a loved one, illness, losing their smartphone and Brexit.
Researchers at the University of California, Santa Cruz, have developed a novel approach for eradicating drug-resistant bacteria from wounds and skin infections, using light to trigger the controlled release of nitric oxide. The UCSC team developed a photoactive compound that releases nitric oxide when exposed to light, and loaded it into a porous, biocompatible material that could be applied as a sprayable powder.
In addition to data released in late November, ChemoCentryx, Inc., announced today more data from the Company's PROTECT-1 (the Prospective Randomized Oral Therapy Evaluation in Crohn's disease Trial) of Traficet-EN(TM) (CCX282-B) in patients with moderate-to-severe Crohn's disease.
› Verified 3 days ago
Lloyd D Tarlin, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 40 Seaver St, Wellesley, MA 02481 Phone: 781-235-6276 | |
Rosina M Mele, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 422 Worcester St, Suite 105, Wellesley, MA 02481 Phone: 781-235-9737 Fax: 781-235-9738 | |
Jameila Y Haddawi, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 230 Worcester St, Wellesley, MA 02481 Phone: 781-431-5230 Fax: 781-431-5518 | |
Dr. Patricia Ann Davis, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 65 Walnut St, Mgh Ladders, Wellesley, MA 02481 Phone: 781-449-6074 | |
Milana Stavitsky, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 422 Worcester St, Suite 103-105, Wellesley, MA 02481 Phone: 781-235-9737 Fax: 781-235-9738 | |
Patricia M Peters, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 230 Worcester St, Wellesley, MA 02481 Phone: 781-431-5230 Fax: 781-431-5518 |